Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Multiple endocrine neoplasia syndromes (MEN1, MEN2, MEN4), Peptide receptor radionuclide therapy (PRRT), Rare cancers, Somatostatin receptor 2 and the tags rare, endocrine.
Shares Corticotroph pituitary neuroendocrine tumour (Cushing disease and silent corticotroph tumour), Endocrine-related cancer, Rare cancers, SBRT / SABR (stereotactic radiotherapy) and the tags rare, endocrine.
Shares Multiple endocrine neoplasia type 1 (MEN1), Multiple endocrine neoplasia syndromes (MEN1, MEN2, MEN4), Rare cancers, Rare and paediatric cancers without markets and the tags rare, endocrine.
Shares Brain tumor pathology, CNS oncology, Journal of neuro-oncology, Vestibular schwannoma (acoustic neuroma) and the tag cns.
Shares Dopamine D2 receptor, Brain tumor pathology, CNS oncology, Journal of neuro-oncology and the tag cns.
Shares Dopamine D2 receptor, Endocrine-related cancer, Somatostatin analogues (octreotide, lanreotide), Multiple endocrine neoplasia syndromes (MEN1, MEN2, MEN4) and the tag endocrine.
Shares Brain tumor pathology, CNS oncology, Journal of neuro-oncology, Central nervous system germ cell tumours (germinoma and non-germinomatous) and the tag cns.
Shares Peptide receptor radionuclide therapy (PRRT), Rare cancers, Somatostatin receptor 2, Lutetium-177 dotatate and the tag endocrine.
The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.